AU Patent

AU6392496A — The combination of topical nasal antihistamines and topical nasal steroids

Assigned to Kenvue Brands LLC · Expires 1997-01-30 · 29y expired

What this patent protects

Patent listed against azelastine-hydrochloride.

Drugs covered by this patent

azelastine-hydrochloride (AZELASTINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU6392496A
Jurisdiction: AU
Classification: —
Expires: 1997-01-30
Drug substance claim: No
Drug product claim: No
Assignee: Kenvue Brands LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.